This is based on the observation that over expression of wild type SIVA in human breast and ovarian cancer cell lines generally suppressed the migration and/or invasion; and over-expression of SIVA-D160N enhanced migration and/or invasion, in a manner like what we expect with SIVA knockdown with shRNA over expression. This evidence concerns the gene SIVA1 and ovarian cancer.